Akero Therapeutics Inc (AKRO)

06:04 AM

How To Trade (AKRO) - Stock Traders Daily

06:04 AM

Nov 20, 2024

NASH Updates: Boston Pharma, Viking Line Up As Serious Competitors - Scrip

Nov 20, 2024

Nov 19, 2024

Akero Therapeutics' chief development officer sells $251,274 in stock - Investing.com

Nov 19, 2024

Nov 19, 2024

Citigroup Initiates Coverage of Akero Therapeutics (AKRO) with Buy Recommendation - MSN

Nov 19, 2024

Nov 18, 2024

Inventiva Getting Back On Track In NASH Development - Citeline News & Insights

Nov 18, 2024

Nov 18, 2024

Akero a new buy at Citi on liver disease asset - Seeking Alpha

Nov 18, 2024

Nov 18, 2024

HC Wainwright Reaffirms "Buy" Rating for Akero Therapeutics (NASDAQ:AKRO) - MarketBeat

Nov 18, 2024

Nov 18, 2024

Citigroup Begins Coverage on Akero Therapeutics (NASDAQ:AKRO) - MarketBeat

Nov 18, 2024

Nov 18, 2024

Citi bullish on Akero stock as efruxifermin targets MASH market leadership - Investing.com Canada

Nov 18, 2024

Nov 15, 2024

Akero Therapeutics (NASDAQ:AKRO) Shares Down 6.4%What's Next? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Akero reports positive EFX trial results for liver disease By Investing.com - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

Akero reports positive EFX trial results for liver disease - Investing.com

Nov 15, 2024

Nov 15, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Boosted by Simplify Asset Management Inc. - MarketBeat

Nov 15, 2024

Nov 15, 2024

Akero Therapeutics to Showcase New Analyses of Phase 2b - GlobeNewswire

Nov 15, 2024

Nov 15, 2024

Akero Therapeutics, Inc. to Showcase New Analyses of Phase 2b Harmony Study in Presentations at 75th Annual AASLD The Liver Meeting®? 2024 - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Sees Large Decline in Short Interest - MarketBeat

Nov 15, 2024

Nov 15, 2024

Janus Henderson Group PLC's Strategic Acquisition of Akero Thera - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

What is HC Wainwright's Estimate for AKRO FY2024 Earnings? - MarketBeat

Nov 14, 2024

Nov 14, 2024

RTW INVESTMENTS, LP Expands Stake in Akero Therapeutics Inc - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Akero Therapeutics to Present at the Jefferies London Healthcare Conference - GlobeNewswire

Nov 13, 2024

Nov 13, 2024

Akero Therapeutics to Present at Jefferies London Healthcare Conference | AKRO Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

ALKEON CAPITAL MANAGEMENT LLC Reduces Stake in Akero Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

FY2028 EPS Forecast for Akero Therapeutics Raised by Analyst - MarketBeat

Nov 13, 2024

Nov 13, 2024

Akero Therapeutics (NASDAQ:AKRO) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 13, 2024

Nov 12, 2024

Akero Therapeutics Advances in MASH Treatment Trials - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Akero Therapeutics Reports Third Quarter 2024 Financial Results and Business UpdateAkero Therapeutics, Inc. made significant strides in the third quarter of 2024, announcing the dosing of the first patient in the Phase 3 SYNCHRONY Outcomes study of i - Defense World

Nov 11, 2024

Nov 10, 2024

(AKRO) Trading Advice - Stock Traders Daily

Nov 10, 2024

Nov 09, 2024

Akero Therapeutics (NASDAQ:AKRO) Releases Earnings Results, Misses Estimates By $0.15 EPS - MarketBeat

Nov 09, 2024

Nov 08, 2024

Akero Therapeutics executive sells $351,890 in stock - Investing.com

Nov 08, 2024

Nov 08, 2024

Akero Therapeutics executive sells $351,890 in stock By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition of Akero Therapeutics Shares - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Akero Therapeutics Inc (AKRO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024

Nov 08, 2024

Akero Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Nov 08, 2024

Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 08, 2024

Nov 08, 2024

Akero Reports $787M Cash Reserve, Advances Phase 3 MASH Drug Trials Despite Higher Costs | AKRO Stock News - StockTitan

Nov 08, 2024

Nov 06, 2024

Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Price Target at $43.20 - MarketBeat

Nov 06, 2024

Nov 05, 2024

Akero Therapeutics COO sells $1.6 million in stock By Investing.com - Investing.com South Africa

Nov 05, 2024

Nov 05, 2024

Akero Therapeutics COO sells $1.6 million in stock - Investing.com

Nov 05, 2024

Nov 05, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Jonathan Young Sells 50,716 Shares - MarketBeat

Nov 05, 2024

Nov 05, 2024

Akero Therapeutics CEO Andrew Cheng sells $3.4 million in stock By Investing.com - Investing.com Nigeria

Nov 05, 2024

Nov 05, 2024

Akero Therapeutics CEO Andrew Cheng sells $3.4 million in stock - Investing.com

Nov 05, 2024

Nov 04, 2024

abrdn plc Trims Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Nov 04, 2024

Nov 02, 2024

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 4,515 Shares of Stock - MarketBeat

Nov 02, 2024

Nov 02, 2024

Akero Therapeutics chief development officer sells $651,960 in stock - Investing.com India

Nov 02, 2024

Nov 01, 2024

Akero Therapeutics chief development officer sells $651,960 in stock By Investing.com - Investing.com Australia

Nov 01, 2024

Oct 30, 2024

Axonis Therapeutics Announces $115 Million Series A Financing - Financial Times

Oct 30, 2024

Oct 29, 2024

Akero Therapeutics (NASDAQ:AKRO) Trading Up 5.8%Here's What Happened - MarketBeat

Oct 29, 2024

Oct 27, 2024

Akero Therapeutics, Inc. (NASDAQ:AKRO) Sees Significant Decline in Short Interest - MarketBeat

Oct 27, 2024

Oct 21, 2024

Akero Therapeutics to Present Data Reinforcing the Efficacy - GlobeNewswire

Oct 21, 2024

Oct 21, 2024

Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024 - StockTitan

Oct 21, 2024

Oct 20, 2024

Akero Therapeutics Insiders Sell US$1.2m Of Stock, Possibly Signalling Caution - Simply Wall St

Oct 20, 2024

Oct 19, 2024

(AKRO) Proactive Strategies - Stock Traders Daily

Oct 19, 2024